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ORIGINAL RESEARCH

HEAD & NECK

Accuracy of 2-Phase Parathyroid CT for the Preoperative
Localization of Parathyroid Adenomas in Primary
Hyperparathyroidism
B. Grifﬁth, H. Chaudhary, G. Mahmood, A.M. Carlin, E. Peterson, M. Singer, and S.C. Patel

ABSTRACT
BACKGROUND AND PURPOSE: Minimally invasive parathyroidectomy requires accurate preoperative localization of suspected adenomas, and multiphase CT allows adenoma characterization while providing detailed anatomic information. The purpose of this study was to
assess the feasibility of a protocol using only arterial and venous phases to localize pathologic glands in patients with primary
hyperparathyroidism.
MATERIALS AND METHODS: We identiﬁed 278 patients with primary hyperparathyroidism who had undergone 2-phase CT with surgical
cure. All scans were read prospectively by board-certiﬁed neuroradiologists. A neuroradiology fellow retrospectively reviewed images and
reports and classiﬁed suspected adenomas on the basis of anatomic location. Accuracy was determined by comparing imaging results with
surgical ﬁndings. The ability of 2-phase CT to localize adenomas to 1 of 4 neck quadrants and lateralize them to the correct side was
assessed. Accuracy of identifying multigland disease was also evaluated.
RESULTS: In patients with single-gland disease, the sensitivity and speciﬁcity of 2-phase CT to correctly localize the quadrant were 55.4%
and 85.9%, respectively. The sensitivity and speciﬁcity of correct lateralization were 78.8% and 67.8%, respectively. The sensitivity and
speciﬁcity to identify multigland disease were 22.9% and 79.5%, respectively.
CONCLUSIONS: While the 2-phase CT protocol in this study demonstrates lower accuracy compared with reports of other techniques,
its lower radiation compared with 3- and 4-phase techniques may make it a feasible alternative for preoperative parathyroid localization.
Further prospective studies are needed to identify patients for whom this technique is most suitable.

P

rimary hyperparathyroidism, a disorder caused by the presence of ⱖ1 hyperfunctioning parathyroid gland, is characterized by the overproduction of parathyroid hormone and is the
most common cause of hypercalcemia in nonhospitalized patients.1-3 Primary hyperparathyroidism is most commonly due to
a single adenoma (85%) but can also be caused by multiple adenomas, 4-gland hyperplasia, and parathyroid carcinoma.2
The treatment of choice for primary hyperparathyroidism is
surgical removal of the hyperfunctional tissue.1 In the past, surgical management required bilateral cervical exploration. Improvements in preoperative localization of abnormal glands, however,
and the use of intraoperative parathyroid hormone assays have
led to increased use of minimally invasive, or focused, parathy-
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roidectomy techniques.3,4 Compared with bilateral exploration,
minimally invasive parathyroidectomy achieves the same outcomes while offering a lower risk profile, causing less pain, and
providing superior cosmetic outcomes.
The success of minimally invasive parathyroidectomy depends on the accurate preoperative localization of a potentially
hyperfunctioning gland. A number of imaging modalities are
currently used, both alone and in combination, for preoperative localization, including radionuclide scintigraphy and radionuclide single-photon emission CT, sonography, and
contrast-enhanced CT. Radionuclide scintigraphy and sonography have both demonstrated success in preoperative localization, but each has limitations as well. In particular, both
modalities lack detail regarding surrounding anatomy, and
sonography is highly operator-dependent.5-7
In the past decade, multiphase CT has emerged as an additional technique for adenoma localization.1,2,8-14 In addition to
lesion identification, CT allows precise localization based on welldefined anatomic landmarks. Following its introduction, multiphase CT was referred to as 4D-CT.9 The term “4D” referred to
the 3 dimensions provided by the CT scan with the added dimenAJNR Am J Neuroradiol 36:2373–79
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sion of time due to the functional information offered by the
multiple phases of imaging.9 Since the initial description of
4D-CT by Rodgers et al9 in 2006, many studies have attempted to
define the optimal number of phases needed for parathyroid adenoma detection.
Two-phase parathyroid CT uses only 2 phases of imaging for
characterization and localization purposes, which, in this study,
included an arterial and a venous phase. Identification of parathyroid adenomas is based on the principle that parathyroid lesions
show rapid enhancement followed by washout, which is demonstrated on the arterial and venous phases, respectively. The obvious major benefit of 2-phase CT over 3- or 4-phase CT is the
decreased radiation dose. This is of particular importance given
the increasing attention paid to radiation exposure from medical
imaging.15 In addition, studies have suggested that multiple
phases do not improve localization, with a recent study finding
that the arterial phase alone was comparable with the combination of other phases in correctly localizing and lateralizing adenomas.16 Our institution began using this 2-phase parathyroid CT
exclusively in 2009 for the preoperative work-up of parathyroid
adenomas when cross-sectional imaging localization was requested by the referring surgeon.
The purpose of this study was to retrospectively assess the
accuracy of 2-phase parathyroid CT for localizing surgically
proved parathyroid adenomas in patients with primary hyperparathyroidism. We hypothesized that 2-phase CT would be a
feasible technique for preoperative localization compared with
techniques using 3 or 4 phases, while offering a reduction in radiation dose.

The decision to obtain a CT scan at our institution is variable
and is determined by the individual surgeons on a patient-bypatient basis. There is no differentiation of patients who had previously undergone successful or unsuccessful localization by
other modalities, whether sestamibi or sonography.

CT Technique
All examinations were performed with a 16 – or 64 – detector row
CT scanner. Patients were positioned supine, head first on the CT
gantry. Examinations included a scout scanogram and 2 phases of
imaging following the intravenous administration of contrast material. One hundred milliliters of iopamidol (Isovue-350; Bracco,
Princeton, New Jersey) or ioversol (Optiray-300; Mallinckrodt,
St. Louis, Missouri) was administered at an injection rate of 5
mL/s via an 18-ga catheter followed by 40 mL of saline at 2 mL/s.
Timing of the 2 phases of imaging (arterial and venous) was
dependent on patient age. In patients older than 55 years, the
first-phase scanning started following a 22-second delay. The delay was 18 seconds in patients younger than 55 years of age. The
second (venous) phase was obtained immediately following the
first phase.
The multiphase CT was acquired at 2.5-mm section thickness
with a 2.5-mm interval. Automatic exposure control was used
(range, 200 – 400 mA) at 120 kV with a noise index of 13.81.
Craniocaudal coverage was from the base of the orbit to the aortic
arch. The mean CT dose index per imaging phase was 24.49 mGy.
Coronal and sagittal reformats were obtained for both phases at
2.5-mm section thickness with a 2.5-mm interval.

Image Analysis

MATERIALS AND METHODS
This retrospective study was conducted in accordance with
Health Insurance Portability and Accountability Act regulations.
The study was approved by our institutional review board, and a
waiver of informed consent was obtained.

Patients
Between May 2009 and August 2013, 444 two-phase parathyroid
CT scans were obtained on 428 patients at our institution. Of
these, 278 patients met the following inclusion criteria:
●
●

Laboratory data consistent with primary hyperparathyroidism
First-time parathyroidectomy surgery with subsequent cure (defined as normal calcium levels at 6 months or a 50% drop in intraoperative parathyroid hormone levels and into the normal range).

One hundred sixty-six CT scans were excluded for the following reasons: Seventy patients underwent 1 or multiple 2-phase CT
scans without surgery performed, 14 patients had operative or
pathology reports that were indeterminate, 18 patients did not
have a cure following surgery, 25 patients had inadequate preoperative documentation, 27 patients were either lost to follow-up
or had no postoperative laboratory data, and 12 patients were
undergoing repeat surgeries.
Of the 278 included patients, 250 had either radionuclide scintigraphy or radionuclide single-photon emission CT performed.
Of those, 140 patients had a suspected adenoma identified on the
scan.
2374
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All 2-phase parathyroid CT reports and images were retrospectively reviewed by a neuroradiology fellow, and suspected adenomas were classified on the basis of their anatomic location: right
upper quadrant, right lower quadrant, left upper quadrant, and
left lower quadrant. Localization was based on a combination of
image annotations (eg, measurements, arrows) placed at the time
of the initial interpretation and the anatomic description on the
report. All initial image interpretations were performed prospectively by board-certified neuroradiologists. No images were reinterpreted by the fellow at review. Quadrants were based on lesion location with respect to the vertical midline (right and left)
and a transverse plane through the middle of the thyroid gland
(Fig 1). Potential adenomas were also assigned a lateralization
(right or left) based on their position relative to the midline. Suspected adenomas crossing a quadrant line were localized to the
quadrant where the greatest proportion of the gland was located.
Nontraditional locations, including ectopic and intrathyroidal
glands, were also identified.

Surgical Localization
The surgery and pathology records were reviewed by a third-year
medical student and a fourth-year otolaryngology resident with all
final determinations of gland location confirmed with an otolaryngology staff member specializing in parathyroid surgery. Because
surgeries were performed by multiple surgeons, if surgical localization could not be confidently determined on the basis of operative
and pathology reports, the patient was excluded from analysis.

Table 1: Patient demographics
Demographics
Age (yr) (n ⫽ 278)
Weight (kg) (n ⫽ 241)
Body mass index (n ⫽ 209)
Preoperative PTH level (n ⫽ 278)a
Intraoperative PTH level (n ⫽ 278)a
Preoperative calcium levela
Multigland disease at surgery
(No. of patients)
Nontraditional-location disease at
surgery (No. of patients)
Single-gland weighta,b (g) (n ⫽ 222)

60.5 ⫾ 12.7
85.23 ⫾ 21
31.4 ⫾ 7.0
128.5 (26.7–1900)
23.6 (0–151.7)
10.6 (8.7–14.6)
48
8
0.481 (0.007–13.5)

Note:—PTH indicates parathyroid hormone.
a
Denotes median value with range (mean and SD for all other values unless speciﬁed).
b
Includes patients with single glands in a traditional location (4 quadrants) removed
at surgery.

FIG 1. Coronal reformat image demonstrates the 4 quadrants used
for imaging localization purposes. Quadrants were based on lesion
location with respect to the vertical midline (right and left) and a
transverse plane through the middle of the thyroid gland.

Gland location was classified by the same method as imaging
localization. Medical records were reviewed to obtain patient demographic data, including age, sex, weight, body mass index, and
preoperative and postoperative parathyroid hormone and calcium levels.
For diagnostic accuracy, surgical and pathologic findings were
treated as the criterion standard.

Statistical Analysis
Suspected adenomas localized to the correct quadrant on the basis of
surgical and pathologic findings were scored as true-positive. Suspected adenomas localized to the incorrect quadrant were scored as
false-positive. The remaining quadrants not identified with possible
adenomas were evaluated as a “no adenoma” guess—if correct on the
basis of surgery, they were classified as a true-negative, and if misclassified, they were considered a false-negative. Each individual had 4
determinations, 1 for each quadrant. Screening parameters of sensitivity, specificity, positive predictive value, and negative predictive
value were estimated by using a ratio estimator commonly used in
sampling theory. Standard errors were also estimated. This estimation was performed for both single-gland quadrant localization and
single-gland lateralization, considering only 2 areas on the 2-phase
CT scan instead of 4.
For purposes of determining the accuracy of multigland identification, true-positives were those patients with multigland disease found at surgery and suspected adenomas identified at multiple locations on CT. False-negatives were those patients found to
have multigland disease at surgery but without suspected multiple
glands identified on CT. True-negatives and false-positives were
those patients with only a single gland found at the time of surgery
and with a single suspected gland or multiple suspected glands
identified on CT, respectively.
Sensitivity, specificity, positive predictive value, and negative
predictive value were compared for both localization and lateralization for those patients with single-gland disease within 1 of the
4 quadrants at the time of surgery. The following variables were

Table 2: Single-gland detection accuracy
Single-Gland
Localization
Sensitivity, %
55.4 ⫾ 3.5
Speciﬁcity, %
85.9 ⫾ 1.4
Positive predictive value, %
56.8 ⫾ 3.4
Negative predictive value, %
85.3 ⫾ 1.1

Single-Gland
Lateralization
78.8 ⫾ 2.8
67.8 ⫾ 3.2
71.0 ⫾ 2.7
76.2 ⫾ 3.1

assessed when information was available: body mass index of
ⱖ30, history of diabetes, prior neck surgery other than parathyroid surgery, presence of hypothyroidism, presence of thyroid
goiter or nodules, history of prior radioiodine treatment for thyroid disease, gland weight (⬎1 g), preoperative parathyroid hormone level (ⱖ150), and calcium level (ⱖ11). A test from sampling theory was used for the independent estimates of sensitivity
in the 2 groups. This test was performed separately for localization
and lateralization.

RESULTS
Patients
Between 2009 and 2013, 278 patients met the inclusion criteria.
Table 1 shows the descriptive data regarding our patient
population.

Localization and Lateralization
Of the 278 patients, 48 (17.3%) had multigland disease found at
surgery and 8 had single glands located outside the 4 quadrants.
These patients were excluded from localization and lateralization
analysis, leaving 222 patients with single-gland disease in 1 of the
4 quadrants.
The sensitivity and specificity of 2-phase parathyroid CT to
correctly localize a single gland to 1 of the 4 quadrants were
55.4% ⫾ 3.5% and 85.9% ⫾ 1.4%, respectively (Table 2). The
positive and negative predictive values for single-gland localization were 56.8% ⫾ 3.4% and 85.3% ⫾ 1.1%, respectively.
The sensitivity and specificity of 2-phase parathyroid CT
to correctly lateralize a single gland were 78.8% ⫾ 2.8% and
67.8% ⫾ 3.2%, respectively. The positive and negative predictive
values for single-gland localization were 71.0% ⫾ 2.7% and
76.2% ⫾ 3.1%, respectively.
We further evaluated the sensitivities and specificities for localization and lateralization for single adenomas on the basis of
specific quadrants. These data are provided in Table 3.
AJNR Am J Neuroradiol 36:2373–79
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Multigland Disease and Nontraditional Location Glands
The ability of 2-phase parathyroid CT to correctly identify the
presence of multiple glands was also assessed. For the 48 patients with multiglandular disease, the sensitivity and specificity of the 2-phase parathyroid CT to correctly identify their
disease was 22.9% ⫾ 6.1% and 79.5% ⫾ 2.7%, respectively.
The positive and negative predictive values were 19.0% ⫾ 5.1%
and 83.1% ⫾ 2.5%.
Eight patients were identified as having nontraditionally located glands at the time of surgery, including 4 patients with
glands identified within the superior mediastinum, 1 patient with
an inferiorly descended superior parathyroid gland in a right
paratracheal location, 1 patient with a gland located within the left
piriform sinus, and 2 patients with intrathyroidal parathyroid adenomas. Mediastinal or ectopic glands in all 6 patients were correctly identified, though the piriform sinus lesion was not prospectively inferred to be an adenoma. The 2 intrathyroidal
adenomas were not identified.

ization and lateralization (Table 4). For localization, only the
gland weight of ⱖ1 g led to a higher sensitivity (69.8% versus
50.0%, P ⫽ .014). The group with a calcium level ⱖ11 had a
higher sensitivity, 62.7%– 49.7%, which demonstrated a trend toward statistical significance (P ⫽ .070). There were no other statistically significant results.
Similarly, patients with a gland weight of ⱖ1 g or a body mass
index of ⬍30 demonstrated higher sensitivity for lateralization
(90.7% versus 71.9%, P ⫽ .001, and 84.0% versus 69.2%, P ⫽
.022, respectively). In addition, patients with a history of hypothyroidism had a lower sensitivity than those without (59.4% versus 77.8%, P ⫽ .049) and lower specificity (46.9% versus 66.1%,
P ⫽ .046).

DISCUSSION

Between 0.2% and 0.5% of the population are affected by primary
hyperparathyroidism, with approximately 100,000 new cases diagnosed annually in the United States.17 In the past, treatment of
primary hyperparathyroidism required subjecting a patient to bilateral cervical exploration. In recent years, however, treatment
Clinical Factors Affecting Accuracy
A variety of clinical factors in patients with single adenomas was
has shifted toward the use of minimally invasive, or focused, paraevaluated for their effects on sensitivity and specificity for localthyroidectomy. A 2011 study by Udelsman et al3 evaluating 1650
patients undergoing surgery for primary
hyperparathyroidism found that paTable 3: Quadrant-speciﬁc single-gland detection accuracy
tients undergoing minimally invasive
Right Upper
Right Lower
Left Upper
Left Lower
parathyroidectomy demonstrated imSensitivity, %
26.2 ⫾ 6.9
73.6 ⫾ 6.1
51.0 ⫾ 7.1
63.8 ⫾ 6.4
proved cure and complication rates and
Speciﬁcity, %
70.6 ⫾ 3.4
95.6 ⫾ 2.0
83.0 ⫾ 2.9
90.8 ⫾ 2.3
Positive predictive value, %
79.2 ⫾ 2.2
89.8 ⫾ 6.1
50.0 ⫾ 6.4
69.8 ⫾ 6.2
a decreased length of hospital stay and
Negative predictive value, %
76.2 ⫾ 3.1
91.6 ⫾ 1.8
83.6 ⫾ 2.2
88.3 ⫾ 1.9
lower total hospital charges.

Table 4: Effect of clinical variables on sensitivity and speciﬁcity of localization and lateralization in patients with single adenomas
Localization
Lateralization
BMI ⱖ 30 (na ⫽ 166)
Sensitivity, %
Speciﬁcity, %
Diabetes (n ⫽ 213)
Sensitivity, %
Speciﬁcity, %
Prior neck surgery (n ⫽ 201)
Sensitivity, %
Speciﬁcity, %
Hypothyroidism (n ⫽ 212)
Sensitivity, %
Speciﬁcity, %
Thyroid goiter or nodules (n ⫽ 218)
Sensitivity, %
Speciﬁcity, %
Radioactive iodine therapy (n ⫽ 218)
Sensitivity, %
Speciﬁcity, %
Gland weight ⱖ1 g (n ⫽ 221)
Sensitivity, %
Speciﬁcity, %
Preoperative PTH level ⱖ 150 (n ⫽ 221)
Sensitivity, %
Speciﬁcity, %
Preoperative calcium level ⱖ11 (n ⫽ 222)
Sensitivity, %
Speciﬁcity, %

Variable: Yes

Variable: No

P Value

Variable: Yes

Variable: No

P Value

48.4
87.9

56.0
82.2

.328
.081

69.2
59.3

84.0
69.3

.022
.180

45.2
88.2

53.3
85.7

.407
.456

71.0
61.3

75.3
63.7

.628
.799

55.0
91.7

53.0
85.6

.870
.99

75.0
75.0

75.7
63.5

.947
.278

43.8
86.5

54.4
85.7

.268
.872

59.4
46.9

77.8
66.1

.049
.046

46.4
87.4

57.0
85.7

.143
.540

69.6
58.0

78.5
67.1

.170
.199

42.9
81.0

53.6
86.3

.602
.596

57.1
42.9

75.8
64.5

.360
.291

69.8
85.3

50.0
86.5

.014
.736

90.7
72.1

71.9
62.4

.001
.213

53.8
84.6

53.1
87.7

.911
0.274

81.3
64.8

71.5
64.6

.087
0.973

62.7
86.1

49.7
86.2

0.070
0.957

80.6
67.2

73.5
63.2

0.242
0.572

Note:—BMI indicates body mass index; PTH, parathyroid hormone.
a
Total number of patients in whom this variable could be conﬁrmed on retrospective chart review.
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dividual patient characteristics, such as
high body mass index, a surgeon may
want additional imaging studies.
In recent years, multiphase CT has
been increasingly used at our institution
as a means of localizing adenomas before surgery in select patients. The
ability of multiphase CT to identify
parathyroid adenomas is dependent on
differences in enhancement characteristics between parathyroid lesions and
other soft-tissue structures in the neck,
with parathyroid lesions demonstrating
FIG 2. Axial arterial phase (A) and axial venous phase (B) images show a left inferior parathyroid rapid uptake and washout of contrast
adenoma, which demonstrates avid early contrast enhancement on the arterial phase and wash- (Figs 2 and 3) versus the progressive enout on the venous phase.
hancement pattern seen in normal
lymph nodes.12 In addition, CT has the
added benefit of providing the surgeon
with exquisite anatomic detail that can
be used for surgical planning.
In 2006, 4D-CT was first reported in
the literature as a means of identifying
parathyroid adenomas. In that study,
patients underwent sestamibi imaging,
sonography, and 4D-CT, which consisted of precontrast, postcontrast, and
delayed images.9 Investigators demonstrated the improved sensitivity (88%)
of 4D-CT compared with sestamibi imaging (65%) and sonography (57%) for
lateralizing hyperfunctioning parathy9
FIG 3. Axial arterial phase (A) and axial venous phase (B) images show an ectopic superior left roid glands to 1 side of the neck. In adparathyroid adenoma, which was surgically found to be within the submucosa of the left piriform dition, the sensitivity of 4D-CT in localsinus.
izing parathyroid tumors to the correct
quadrant of the neck was 70% compared
The success of minimally invasive parathyroidectomy depends
with only 33% and 29% for sestamibi and sonography,
on the appropriate selection of candidates—namely, those with
respectively.9
localizable adenomas on preoperative imaging.18 A number of
Since that initial report by Rodgers et al in 2006,9 many studies
imaging modalities, including radionuclide scintigraphy, sonoghave attempted to determine the number of imaging phases
raphy, and CT, are currently used, both alone and in combinaneeded to optimize parathyroid adenoma detection. A 2011 study
tion, for localization purposes, with varying levels of success.
by Starker et al10 found that a 4D-CT consisting of 4 phases (preA prior meta-analysis of 20,225 cases of primary hyperparacontrast followed by imaging at 30, 60, and 120 seconds following
thyroidism demonstrated radionuclide scintigraphy having a senintravenous contrast injection) had improved sensitivity (85.7%)
sitivity of 88% for detecting solitary adenomas,19 though the sencompared with sestamibi with SPECT (40.4%) and ultrasound
sitivity decreased to between 51% and 69% for adenomas of ⱕ500
(48.0%) for localizing parathyroid adenomas to the correct quadmg.20,21 Similarly, sonography is reported to have sensitivities for
rant of the neck. That study showed similar superiority of 4D-CT
lateralization ranging from 61% to 88%. Many consider sonografor lateralizing parathyroid lesions as well (93.9% for 4D-CT,
phy to be the first-line imaging study, due to its ability to localize
71.2% for ultrasound, 61.5% for sestamibi with SPECT).10 Simienlarged parathyroid glands while concurrently determining the
larly, a study by Eichhorn-Wharry et al14 found 4-phase CT to be
presence of relevant thyroid disease. Both of these modalities are
significantly more sensitive than sestamibi in correctly lateralizing
plagued by poor spatial resolution, however, and sonography is
parathyroid adenomas (73% versus 62%), with an even greater
limited in its ability to adequately visualize the mediastinum.13 In
difference seen in patients with serum calcium levels of ⬍10.8
mg/dL (45% versus 29%). Additional studies by Beland et al12 and
addition, sonography is user-dependent and, as such, is limited by
22
Hunter et al13 also evaluated 4D-CT with 4 imaging phases. In the
the skill and experience of the ultrasonographer.
former, investigators found a sensitivity of 82% and a specificity
Regardless of the preferred technique, in select patients, neiof 92%. In the latter, Hunter et al found 4D-CT to have a 93.7%
ther sonography nor radionuclide scintigraphy provides adequate
accuracy for correct lateralization and an 86.6% accuracy for
localizing information. These patients may benefit from further
attempts at preoperative localization. In addition, because of inquadrant localization.
AJNR Am J Neuroradiol 36:2373–79
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Investigators have also evaluated the use of 3-phase 4D-CT.
Chazen et al,23 by using 3 phases consisting of precontrast, postcontrast, and delayed, found a sensitivity for correct lateralization
of 93% and correct localization of 92% in 32 pathologically
proved cases of single parathyroid adenomas. Similarly, Sepahdari et al24 reported 97% accuracy for single-gland disease in a
3-phase protocol with precontrast, arterial, and venous phase
imaging.
Finally, Kutler et al11 used a modified technique of 4D-CT/
sonography to identify parathyroid adenomas and found that it
had a sensitivity and specificity of 94% and 96%, respectively, for
lateralizing hyperfunctioning parathyroid glands and 82% and
93%, respectively, for localizing abnormal parathyroid glands to 1
quadrant of the neck. A similar study found that this technique
demonstrated a good sensitivity for localization even in adenomas
weighing ⬍150 mg.1
Despite high reported localization success rates, 4D-CT remains burdened by the substantial radiation dose associated with
scanning the patient multiple times. In addition, the optimal
number of phases and the timing of contrast are still under investigation. In fact, a recent study by Raghavan et al16 evaluated the
accuracy of different combinations of CT phases to accurately
localize parathyroid adenomas in 29 patients with primary hyperparathyroidism and found that the lateralization and localization
accuracy of the arterial phase alone were comparable with that in
other combinations of phases.
Our study, which includes 278 patients with surgically
cured primary hyperparathyroidism, is the largest to date evaluating the accuracy of multiphase CT in preoperatively localizing pathologic parathyroid glands. Compared with the literature, our findings demonstrate a more modest success rate of
our 2-phase CT protocol, with an overall sensitivity of 55.4%
and specificity of 85.9% for localizing disease to a specific
quadrant, which are less than those reported by others in the
literature.1,9,10,12,13,23 Similarly, the success of 2-phase CT to
correctly lateralize adenomas, with a sensitivity and specificity
of 78.8% and 67.8%, respectively, is also less than that reported
for 4-phase CT in the literature.
A number of factors could account for the decreased accuracy
of 2-phase CT in this study. The most important is related to study
design, because this was a retrospective analysis designed specifically to reflect the performance of 2-phase-CT in a true clinical
setting. As such, the study is prone to the same limitations that
affect radiologists’ interpretations on a routine clinical basis.
These include issues related to the following: 1) patient factors,
such as streak artifacts from the shoulders and clavicles, and artifacts related to breathing and swallowing; 2) gland-specific factors
that may hinder accurate characterization by dynamic CT, such as
in the case of cystic adenomas; 3) technical factors related to
the CT scan itself, such as poor contrast bolus timing and
streak artifacts due to venous contrast pooling; and 4) finally,
interpretation-related factors, such as differences in reader experience and skill in interpreting 2-phase studies. Although
these factors influence the sensitivity and specificity of parathyroid CT studies regardless of the number of phases performed, these may be less apparent in more controlled settings
2378
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with smaller sample sizes of patients and smaller numbers of
more experienced readers.
An additional factor that could potentially affect the accuracy
of this 2-phase protocol in identifying parathyroid adenomas is
problems with differentiating juxtathyroidal adenomas from thyroid tissue because both can have similar contrast-enhancement
characteristics. As such, the lack of a precontrast phase may limit
the ability to accurately identify juxtathyroidal adenomas, particularly in the setting of multinodular goiter, but our analysis of
clinical factors affecting the accuracy of detection did not find a
difference between patients with multinodular goiter and those
without.
Additional factors in this study must also be taken into account as well. First, the 4-quadrant classification system used in
this study is unable to differentiate an inferior parathyroid adenoma from a superior parathyroid adenoma that has overly descended along the tracheoesophageal groove. At imaging, this
gland would be classified in the inferior quadrant due to its relationship with the thyroid, while at surgery it would be classified as
a superior gland. This study did not attempt to differentiate these
glands on imaging. This limitation is reflected in the quadrantspecific analysis of sensitivity, with the upper quadrants demonstrating lower sensitivities compared with the lower quadrants
(26.2% and 51.0% versus 73.6% and 63.8%). An additional limitation relates to the study-selection criteria—in particular, exclusion of 18 patients who were not cured following surgery. Unfortunately, this limitation is due to the retrospective design of the
study and was necessary because surgical localization was treated
as the criterion standard, without which the accuracy of the technique could not be determined. However, this failed cure rate of
6.1% (18 of 296 patients) is not much different from the failure
rate of up to 5% often reported in the literature, and the small
difference may reflect a slightly more surgically challenging patient population requiring 2-phase CT.25-27 Similarly, patients
undergoing repeat surgery (12 of 296 patients) were excluded because the purpose of this study was to evaluate the accuracy of
2-phase CT in patients at initial presentation.

CONCLUSIONS
Two-phase parathyroid CT offers an additional potential
method for the preoperative localization of parathyroid adenomas with sensitivities for lateralization and quadrant-specific localization of 78.8% and 55.4%, respectively. Despite
lower accuracy rates than those of 4D-CT techniques in the
literature, the lower accuracy rates must be balanced with the
potential reduction in radiation dose. In addition, the clinical
environment in which this study was performed, which subjects radiologists to the same limitations routinely encountered during study interpretation, may more fairly represent
the accuracy of this technique when implemented in everyday
clinical practice. Further large cohort prospective studies are
needed to definitively determine the optimal number of phases
required and the appropriate population for each technique.
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